Limited detection of Gulf War illness-like behavioral phenotypes in Charles River male Sprague-Dawley rats across multiple chemical and stress exposure paradigms.

Authors

Rashelle Lashley, Joshua Brian Foster, Xueqin Wang, Albert John Muhleman, Samuel Weaver, Edison Lin, Liching Lai, Chien-Liang Glenn Lin

Published in

PloS one. Volume 21. Issue 9. Pages e0337157. Epub Sep 30, 2026.

Abstract

Gulf War illness (GWI) is characterized by a range of neurological and neuropsychiatric symptoms, including chronic pain, fatigue, mood problems, and cognitive impairment. The pathophysiology is associated with war-related environmental chemical exposure and psychological stress, which are known to disrupt glutamatergic synaptic structure and function. The original objective of this study was to evaluate the efficacy of LH-001, an investigational compound designed to enhance tripartite glutamatergic synapses, in a rat model of GWI. We initially attempted to induce GWI-like behavioral phenotypes in Charles River male Sprague-Dawley (SD) rats using a previously published protocol employed for male SD rats from Harlan involving exposure to Gulf War-related chemical agents and mild stress. Because robust behavioral phenotypes were not detected, we subsequently modified the induction protocol by increasing chemical exposure intensity and stress levels. Despite these adjustments, GWI-like behavioral phenotypes were not detected under the experimental conditions evaluated. To better interpret these findings, we compared our protocol and outcomes with previously published GWI rat studies. This comparison revealed substantial variability across studies in exposure paradigms, animal sources, timing of behavioral assessments, and reported outcomes. Collectively, our findings suggest that detection of GWI-like behavioral phenotypes in rats may be sensitive to experimental conditions and highlight the importance of continued efforts to validate, optimize, and standardize animal models to improve translational rigor and support preclinical therapeutic development.

PMID:
42814722
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.